| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/12/2002 | CN1353753A Oligouncleotide for detection and identification of mycobacteria |
| 06/12/2002 | CN1353752A Methods for constructing DNA library and support carrying DNA library immobilized thereon |
| 06/12/2002 | CN1353751A NOvel endo-beta-1,4-glucanases |
| 06/12/2002 | CN1353678A Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor |
| 06/12/2002 | CN1353575A i(in Vitro) induction of antigen-specific T-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens |
| 06/12/2002 | CN1353192A Method for producing objective fermentation product |
| 06/12/2002 | CN1353189A Efficient expression box of filamentous blue-green alga and carrier containing said expression box |
| 06/12/2002 | CN1353188A Seed-specific expressed promotor and process for breeding rape containing high content of oleic acid with said promotor |
| 06/12/2002 | CN1353187A Vegetable lectin gene |
| 06/12/2002 | CN1353186A Human homoeobox gene LHX4 full-length cDNA sequence |
| 06/12/2002 | CN1353185A Recombinant adenovirus of bone morphogenetic protein and its method for exciting bone generation |
| 06/12/2002 | CN1353183A Establishing recombinant strain of BCG vaccine and its application |
| 06/12/2002 | CN1353115A Synthesis and expression of recombinant human parathyroxin gene |
| 06/12/2002 | CN1353114A Human papillomavirus 11L1-E7 recombination protein and its application |
| 06/12/2002 | CN1086201C Reagent box for extracting DNA fast and use thereof |
| 06/12/2002 | CA2364392A1 Compound |
| 06/11/2002 | USRE37741 Purified nontypable Haemophilus influenzae P5 protein as a vaccine for nontypable Haemophilus influenzae infection |
| 06/11/2002 | US6404779 System and method of disharmonic frequency multiplexing |
| 06/11/2002 | US6403865 Fertile transgenic maize plant comprising foreign dna sequence encoding bacillus thuringiensis insecticidal protein toxic to european corn borer stably incorporated into genome which expresses protein in leaf tissue causing mortality to borer |
| 06/11/2002 | US6403864 Precursor polypeptide of a plant growth factor, a gene encoding a precursor polypeptide of a plant growth factor and a method for promotion of plant growth |
| 06/11/2002 | US6403863 Heat stable mutants of starch biosynthesis enzymes |
| 06/11/2002 | US6403862 Isolated promoter capable of driving transcription in seed-preferred manner which comprises polynucleotide having specified sequence |
| 06/11/2002 | US6403861 Production of pathogen resistant plants |
| 06/11/2002 | US6403860 Ku80 homologue and uses thereof |
| 06/11/2002 | US6403859 Polynucleotide encoding pyridoxal kinase polypeptide involved in vitamin b6 metabolism in plants and seeds |
| 06/11/2002 | US6403786 Compounds used to label, detect and sequence nucleic acids |
| 06/11/2002 | US6403785 Isolated DNA molecule encoding human TSC403 |
| 06/11/2002 | US6403784 Human uncoupling proteins and polynucleotides encoding the same |
| 06/11/2002 | US6403782 Nucleic acid encoding eotaxin |
| 06/11/2002 | US6403775 Erythronolide compounds |
| 06/11/2002 | US6403769 Fusion protein having nonantibody portion comprised of effector domain from growth factor or growth factor receptor joined to aminoterminal end of immunoglobulin g-derived sequence which lacks ch1 domain |
| 06/11/2002 | US6403768 Manipulation of Mlo genes to enhance disease resistance in plants |
| 06/11/2002 | US6403767 Polypeptide molecules of the G protein-coupled heptahelical receptor superfamily and uses therefor |
| 06/11/2002 | US6403765 Truncated Apaf-1 and methods of use thereof |
| 06/11/2002 | US6403764 Variant wherein amino acid residue at position 16 of native-sequence human igf-1 is replaced with glycine or serine, or amino acid residue at position 25 or 49 or residues at 3 and 49 are replaced with alanine, glycine, or serine |
| 06/11/2002 | US6403561 Disorders associated with the inactivation or excessive degradation of cholecystokinin; inhibiting the enzymatic hydrolysis of cholecystokinin 1-(2(s)-aminobutyryl)-2(s)-indolinecarboxylic acid |
| 06/11/2002 | US6403559 C-kit ligand-based method for expanding peripheral blood cell levels |
| 06/11/2002 | US6403557 Fibroblast growth factor-13 |
| 06/11/2002 | US6403552 Ob receptor and methods for the diagnosis and treatment of body weight disorders |
| 06/11/2002 | US6403374 Long wavelength engineered fluorescent proteins |
| 06/11/2002 | US6403373 Isolated nucleic acid molecules associated with colon, renal, and stomach cancer and methods of using these |
| 06/11/2002 | US6403372 Aspergillus fumigatus profilin |
| 06/11/2002 | US6403371 Cassettes for the expression of storable proteins in plants |
| 06/11/2002 | US6403370 Generation an infection, reproduction, genetic engineering |
| 06/11/2002 | US6403362 Systems for the mass production of proteins or peptides by microorganisms of the genus humicola |
| 06/11/2002 | US6403361 Enzymatic method for modification of recombinant polypeptides |
| 06/11/2002 | US6403360 Isolated nucleic acids |
| 06/11/2002 | US6403358 21529, a novel adenylate cyclase |
| 06/11/2002 | US6403357 Thermostable D-hydantoinase and the application thereof |
| 06/11/2002 | US6403356 Mutant penicillin G acylases |
| 06/11/2002 | US6403355 Amylases |
| 06/11/2002 | US6403354 Dna from bacillus; genetic engineering |
| 06/11/2002 | US6403352 Compositions and methods for production of male-sterile plants |
| 06/11/2002 | US6403349 Elongation of polyunsaturated fatty acid such as linolenic acid to dihomogamma linolenic acid; nucleotide sequence encodes polypeptide; genetic engineering; animal feeds, nutrients, cosmetics |
| 06/11/2002 | US6403348 Controlled electroporation and mass transfer across cell membranes |
| 06/11/2002 | US6403342 DNA coding for mutant isopropylmalate synthase L-leucine-producing microorganism and method for producing L-leucine |
| 06/11/2002 | US6403341 Magnesium precipitate hot start method for PCR |
| 06/11/2002 | US6403337 Staphylococcus aureus genes and polypeptides |
| 06/11/2002 | US6403336 Dna segment encodes protective peptide-fused atriopeptin; microorganisms transformed with vectors; genetic engineering |
| 06/11/2002 | US6403335 Amino acid sequence; promotes survival of mesencephalic cells; nervous system and degenerative disorders; parkinson*s disease; genetic engineering |
| 06/11/2002 | US6403331 Mutant proteolytic enzymes and method of production |
| 06/11/2002 | US6403327 Diagnostic method using expression of MN/CA9 protein in ASCUS Pap smears |
| 06/11/2002 | US6403323 Ampa-binding human GluR3 receptors |
| 06/11/2002 | US6403319 Mixing nucleic acid samples with hairpin primers; incubation, amplification, hybridization, and detection; sequence determination, genetic engineering |
| 06/11/2002 | US6403318 Fatty acid synthase mRNA binding protein |
| 06/11/2002 | US6403316 Isolation of cDNA encoding for secreted or membranal proteins |
| 06/11/2002 | US6403315 Sequencing by hybridization; exposing array of probes and target nucleic acid with labeled probe; discriminating between full complementarity and one base mismatch; covalently bonding; analzying |
| 06/11/2002 | US6403313 Fluorescent intensity assay for duplex and triplex nucleic acid hybridization solution utilizing fluorescent intercalators |
| 06/11/2002 | US6403312 Protein design automatic for protein libraries |
| 06/11/2002 | US6403309 High throughput assay; hybridization of probes; detecting signals from solid phase; removal of mismatched base parts with enzymes |
| 06/11/2002 | US6403308 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
| 06/11/2002 | US6403307 Amplification of genomic dna or mrna or complement; analyzing for mutation |
| 06/11/2002 | US6403306 Detection and diagnosis of meningococcal strains; vaccines with capsular polysaccharide conjugates; genetic engineering |
| 06/11/2002 | US6403304 Human osteoclast-specific and -related DNA sequences |
| 06/11/2002 | US6403302 Methods and compositions for triple helix formation |
| 06/11/2002 | US6403299 Transforming non-leflunomide resistant cell with dna sequence encoding deah box protein that binds atp and nucleic acid; culturing; modulating helicase activity; genetic engineering |
| 06/11/2002 | US6403103 Cytoplasmic protein fragment selected from: the amino acid sequence from residue 402 to residue 426 of seq id no: 2; and an immunogenic fragment of said amino acid sequence comprising at least residue 408 to residue 417 of said amino acid |
| 06/11/2002 | US6403102 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/11/2002 | US6403101 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/11/2002 | US6403099 Conjugates formed from heat shock proteins and oligo-or polysaccharides |
| 06/11/2002 | US6403097 Deletion in the glycoprotein ge-gene |
| 06/11/2002 | US6403094 Clostridium perfringens vaccines |
| 06/11/2002 | US6403093 Methods to detect granulocytic ehrlichiosis |
| 06/11/2002 | US6403091 Produced by the hybridoma having atcc accession no. hb 10916. |
| 06/11/2002 | US6403089 Inhibitors of fgl2; bacterial and viral infections, allograft and xenograft rejection, glomerulonephritis, cancer, gastrointestinal diseases and fetal loss; monoclonal and polyclonal antibodies which bind to fgl2 and prevent fibrin |
| 06/11/2002 | US6403088 Antibodies reactive with VEGF-C, a ligand for the Flt4 receptor tyrosine kinase (VEGFR-3) |
| 06/11/2002 | US6403087 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of immunological disease |
| 06/11/2002 | US6403082 Administering polynucleotide |
| 06/11/2002 | US6403080 Methods of modulating an immune response to antigen, and cells for use in the method |
| 06/11/2002 | US6403077 Treatment regimes featuring an IL-10-containing chimeric polypeptide |
| 06/11/2002 | CA2329858A1 Expression cloning of protein targets for phospholipids |
| 06/11/2002 | CA2194375C Chondroitin lyase enzymes |
| 06/11/2002 | CA2169629C Human erythropoietin receptor fragment and antibodies thereto |
| 06/11/2002 | CA2152266C Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/turyosinase peptide antigens |
| 06/11/2002 | CA2124218C Cytotoxic drug therapy |
| 06/11/2002 | CA2095861C Structural proteins from artificial genes |
| 06/11/2002 | CA2088478C Cloning and expression of a rhoptry associated protein of p. falciparum |
| 06/11/2002 | CA2082390C Dna encoding human 5-ht1d receptors and uses thereof |
| 06/11/2002 | CA2073186C Gene deleted in colorectal cancer in humans |
| 06/11/2002 | CA1341367C Enhanced production of proteins by cell culture |